The Medicines Monitoring Unit (MEMO) is a University-based organisation that has access to data generated within the UK National Health Service (NHS). MEMO uses record-linkage techniques to carry out studies to detect and quantify adverse effects of drugs in the community. Currently, MEMO utilises data from the Tayside region of Scotland, which is geographically compact and serves over 400 000 patients. A computerised record of all patients registered with a general practitioner and inpatient hospital morbidity and mortality data are available to MEMO and form the backbone of the record-linkage system.
Although MEMO was originally set up for pharmacoepidemiologic research and this is still the main focus of its research activities, recent advances mean that studies in outcomes research, general epidemiology and health economics are also possible.
Was this article helpful?